| In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target RT Manguso, HW Pope, MD Zimmer, FD Brown, KB Yates, BC Miller, ... Nature 547 (7664), 413-418, 2017 | 1021 | 2017 |
| An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background D Mitra, X Luo, A Morgan, J Wang, MP Hoang, J Lo, CR Guerrero, ... Nature 491 (7424), 449-453, 2012 | 560 | 2012 |
| Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy MT Chow, AJ Ozga, RL Servis, DT Frederick, JA Lo, DE Fisher, ... Immunity 50 (6), 1498-1512. e5, 2019 | 491 | 2019 |
| The melanoma revolution: from UV carcinogenesis to a new era in therapeutics JA Lo, DE Fisher Science 346 (6212), 945-949, 2014 | 480 | 2014 |
| Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade ZA Cooper, VR Juneja, PT Sage, DT Frederick, A Piris, D Mitra, JA Lo, ... Cancer immunology research 2 (7), 643-654, 2014 | 263 | 2014 |
| How does pheomelanin synthesis contribute to melanomagenesis? Two distinct mechanisms could explain the carcinogenicity of pheomelanin synthesis AM Morgan, J Lo, DE Fisher Bioessays 35 (8), 672-676, 2013 | 112 | 2013 |
| Growth control of Golgi phosphoinositides by reciprocal localization of sac1 lipid phosphatase and pik1 4‐kinase F Faulhammer, S Kanjilal‐Kolar, A Knödler, J Lo, Y Lee, G Konrad, ... Traffic 8 (11), 1554-1567, 2007 | 92 | 2007 |
| Prognostic significance of cutaneous adverse events associated with pembrolizumab therapy JA Lo, DE Fisher, KT Flaherty JAMA oncology 1 (9), 1340-1341, 2015 | 67 | 2015 |
| Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses JA Lo, M Kawakubo, VR Juneja, MY Su, TH Erlich, MW LaFleur, ... Science translational medicine 13 (581), eabd8636, 2021 | 64 | 2021 |
| FOXD3 regulates VISTA expression in melanoma SR Rosenbaum, M Knecht, M Mollaee, Z Zhong, DA Erkes, PA McCue, ... Cell reports 30 (2), 510-524. e6, 2020 | 64 | 2020 |
| Gain-of-function genetic alterations of G9a drive oncogenesis S Kato, QY Weng, ML Insco, KY Chen, S Muralidhar, J Pozniak, JMS Diaz, ... Cancer discovery 10 (7), 980-997, 2020 | 56 | 2020 |
| Spatially resolved single-cell translatomics at molecular resolution H Zeng, J Huang, J Ren, CK Wang, Z Tang, H Zhou, Y Zhou, H Shi, ... Science 380 (6652), eadd3067, 2023 | 53 | 2023 |
| NNT mediates redox-dependent pigmentation via a UVB-and MITF-independent mechanism J Allouche, I Rachmin, K Adhikari, LM Pardo, JH Lee, AM McConnell, ... Cell 184 (16), 4268-4283. e20, 2021 | 44 | 2021 |
| SOX10 regulates melanoma immunogenicity through an IRF4–IRF1 Axis S Yokoyama, A Takahashi, R Kikuchi, S Nishibu, JA Lo, M Hejna, ... Cancer research 81 (24), 6131-6141, 2021 | 42 | 2021 |
| A structure-based mechanism for tRNA and retroviral RNA remodelling during primer annealing SB Miller, FZ Yildiz, JA Lo, B Wang, VM D’Souza Nature 515 (7528), 591-595, 2014 | 35 | 2014 |
| Vitamin D deficiency exacerbates UV/endorphin and opioid addiction LV Kemény, KC Robinson, AL Hermann, DM Walker, S Regan, YW Yew, ... Science Advances 7 (24), eabe4577, 2021 | 31 | 2021 |
| Dermatology consultation reduces interruption of oncologic management among hospitalized patients with immune-related adverse events: A retrospective cohort study ST Chen, GE Molina, JA Lo, S Durbin, JV Cohen, KL Reynolds, ... Journal of the American Academy of Dermatology 82 (4), 994-996, 2020 | 27 | 2020 |
| Spatiotemporally resolved transcriptomics reveals the subcellular RNA kinetic landscape J Ren, H Zhou, H Zeng, CK Wang, J Huang, X Qiu, X Sui, Q Li, X Wu, ... Nature Methods 20 (5), 695-705, 2023 | 21 | 2023 |
| The significance of pressure injuries and purpura in COVID-19 patients hospitalized at a large urban academic medical center: A retrospective cohort study R Rrapi, S Chand, JA Lo, CK Gabel, S Song, Z Holcomb, C Iriarte, ... Journal of the American Academy of Dermatology 85 (2), 462, 2021 | 15 | 2021 |
| Inpatient admissions related to immune-related adverse effects (irAE) among patients treated with immune checkpoint inhibitors for advanced malignancy: a tsunami is coming, but … KL Reynolds, JV Cohen, S Durbin, M Thomas, M Dougan, HS Martinson, ... Journal of Clinical Oncology 36 (5_suppl), 127-127, 2018 | 15 | 2018 |
